José Borghi has worked hard, for his success.

José Borghi is the creator of Mullen Lowe, a commercial advertising firm, in Brazil. The venture was previously known as, Borghi Lowe. The group is known to be in the midst of the most influential and outstanding advertising agencies, so far, in Brazil. José Borghi is the mastermind who produced the tremendously stylish, advertising promotion in Brazil, that prominently featured kids, who danced and sang songs, while dressed up, as a variety of stuffed animals.

José Borghi’s exceedingly profitable career in the advertising sector, began with various misgivings and several obstacles for him to overcome. During his stint in middle school, José experienced a sense of misgiving, relating to, which career he ought to embark on. These misgivings, vanished, when José’s sister, requested that he attend a display of videos, at the Castro Neves Theater. The presentation showcased a variety, of the most successful advertising commercials in Brazil. All of the presented videos, had been awarded with the esteemed Lion Award, from Cannes. While screening the videos, José was intensely stimulated and wanted to acquire a Lion Award, himself. This longing, led José to follow a career path of promotional advertising, as his craft.

José labored diligently, to fruitfully study at the well-regarded PCU, in Sao Paulo State. When José graduated, he took up employment, at the famous enterprise, Standart Ogilvy. José made the effort to work at many advertising groups in Brazil. Some of these, included FCB, Leo Burnett and DM9/DDB, before he finally established his own advertising group. José and Erh Ray together, founded the agency, BorghiErh.

The renowned accomplishments of their advertising group, soon garnered the focus of the Brazilian marketing firm, Lowe. They soon, merged together, to develop into Mullen Lowe, this, after Lowe fused, with the Mullen Group. for more.

EOS Lip Balm Keeps Your Lips Moist For The Long Term

Are you aware that there are some lip balm companies that do not necessarily have their customers’ best interest in mind? If so, then you may be delighted to know that there is indeed a lip balm company in the market that offers its customers a wonderful product. That company is EOS Lip Balm.

EOS has been noted as being a great company because of the guarantee it delivers to its customers. Unfortunately, there are many companies that state that they will provide their customers and/or clients with something of high quality, but when it comes to the utilization of such products, the customers are left unsatisfied. If this happens to be your case, particularly in the case of lip balm, then you should know that EOS lip balm is a brand that you can depend on to keep your lips moist and healthy throughout the duration of your usage.

Many people often find themselves having a difficult time in keeping their lips moist for a long time. The issue exists when they put on lip balm and it leave their lips dry again within a few minutes. If you happen to be one of those people, then you have probably come across a lip balm company that is not delivering on its promise. Every customer has the right to invest in a product that they are expecting and not let down. EOS lip balm is aware of this and therefore manufacture their product in a way that they are sure their customers will not be dissatisfied with the results. They ensure the product has undergone lab testing and that their customers will have healthy lips for as long as they continue using the product on a regular basis like they would with any other lip balm. The difference with EOS lip balm is that one’s lips will not dry soon after having it applied. EOS products are available on Walmart and target stores. The products are also available online thru Amazon, eBay and other websites.

Jeanmarie Guenot’s Achievements in the Biotech and Pharmaceutical Industry


Jeanmarie Guenot is an entrepreneur in the pharmaceutical and biotechnology field. She has over two decades’ experience in this industry and is an expert at what she does. She has worked with many companies, both private and public, and in different stages of the business lifecycle. She is, therefore, well versed in the management and operation of different types of companies. Besides management, Dr. Guenot has worked in the research and development department of various pharmaceutical companies. Some of the companies she has worked with include PDL BioPharma and Hoffman-La Roche. She holds an MBA from the University of Pennsylvania and a PhD from the University of California.


Dr. Guenot founded a company incubator known as SKS Ocular. Its main focus was the provision of solutions for various ophthalmic issues. She also founded Guenot LLC, a company that provides pharmaceutical and biotech companies with excellent consultation services including financial advice, project management and business restructuring advice among other services. Jeanmarie Guenot is currently the president and CEO of Amphivena Therapeutics.


Amphivena Therapeutics developing a new drug


Amphivena Therapeutics is a company that develops immunotherapies for cancer treatment. It is based in San Francisco, CA and has been in operation since July 2013.Under Dr. Guenot’s leadership, the company strives to improve the lives of cancer patients by developing treatments for various cancers, especially those affecting the blood. Amphivena is performing exceptionally well in the pharmaceutical industry, carrying out extensive high-quality research on different cancers. The company’s latest development is a new drug intended to be used in the treatment of acute myeloid leukemia (AML). It is currently in the clinical development stage and Amphivena hopes to launch it as soon as it is approved for use by the FDA.


Bottom Line


Dr. Guenot’s expertise in the pharmaceutical industry has proven to be a valuable asset in her current position at Amphivena Therapeutics. Her background in research and development makes her well suited for the position. Jeanmarie’s excellent leadership skills are what have enabled the company to make such remarkable progress in the development of treatments for blood cancer in just three and a half years.  Follow more of Jeanmarie Guenot and Amphivena’s mission at the official website.